Professor of Pharmaceutical and Healthcare Marketing
Saint Joseph's University
Philadelphia Pennsylvania UNITED STATES
Dr. Thani Jambulingam Ph.D,is Professor in the Department of Pharmaceutical and Healthcare Marketing at St Joseph’s University, Erivan K. Haub School of Business, in Philadelphia. Dr. Jambulingam teaches both in Executive Pharmaceutical & Healthcare MBA program and undergraduate program in Pharmaceutical and Healthcare Marketing. He has served as the chair of the Department for 8 years and launched the first EMBA online program at SJU in 2002. He is trained at Harvard in case method for teaching. Dr Jambulingam worked in the Glaxo for several years in marketing before his Ph.D., at University of Wisconsin, Madison, USA. Dr. Jambulingam’s research interests are in pharmaceutical and healthcare innovation, launch strategy and marketing. His work has been published in several refereed academic journals and trade publications in marketing, and management. Dr. Jambulingam has served as the external reader for Ph.D. dissertations at Columbia University. Dr. Jambulingam is a visiting Professor for Wharton MBA program in their global programs in India. He is also a faculty at the Biotechnology Entrepreneurship Bootcamp held every year during the BIO International Convention. He has served as a consultant and facilitated educational training sessions in strategy for senior leadership and/or brand teams within several small, mid and large pharmaceutical firms including Alkermes, Abbott, Astra Zeneca, Merck, Novo Nordisk, Pfizer, Solvay and Procter & Gamble. Recently Dr. Jambulingam, as a Pfizer fellow spent a year at Pfizer with the Prevnar Global Commercial Team contributing to developing healthy aging platform development, franchise positioning, vaccine business strategy, and pediatric expanded age expansion strategy (life cycle management). He conducted strategy session for executive leadership within the specialty care division of Pfizer. Dr. Jambulingam has received outstanding teaching and research awards at SJU. He serves in the board of two start up companies.
None yet.